Women who identify as "single by choice" are on the rise. But why does society still view happily single women as desperate?

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today that it has ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, ...

Caroline Morgan gave birth to twins after she underwent years of IVF at Royal Derby Hospital. Here, she shares her inspiring ...

FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --ATLANTA, Feb.

The UK's first comprehensive evaluation of the use of Artificial Intelligence (AI) in breast cancer screening found that it can increase breast cancer detection by 10.4% and has the potential to ...

Cryptocurrency exchange and wallet provider Blockchain.com has won regulatory approval in the U.K nearly four years after seemingly giving up. Blockchain.com was added to the Financial Conduct ...

A surgeon in London has successfully removed a patient’s prostate in Gibraltar using a ...

Beyond symptoms like burning, swelling, itching, and general irritation, it can even interfere with your ability to conceive.

Following the launch of Fujifilm Biotechnologies’ massive new cell culture facility in North Carolina last year, the CDMO is headed across the Atlantic for the next pit stop on its global expansion ...